UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis
Go back to UPDATE: Dyax Corp. (DYAX) Slammed; to Discontinue Ecallantide Phase 2 Based on Results of Interim Analysis| Dyax Corp (NASDAQ: DYAX) | Delayed: 38.41 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $38.41 | 52 Week High | $38.56 | |||
| Open | $31.66 | 52 Week Low | $14.06 | |||
| Day High | $38.41 | P/E | N/A | |||
| Day Low | $38.41 | EPS | $-0.30 | |||
| Volume | 176 | |||||
